Issuance of Stock-Option-Based Equity Compensation for Directors
First written in FY2018-Q2. 3 of 8 entries say "Advanced", first in FY2019-Q2. Latest entry: FY2026.
- FY2026Update to Stock-Option Exercise ResultsAnnual report
「The stock options outstanding during the consolidated fiscal year ending March 2026 are covered, and the number of stock options is stated on a share-equivalent basis.」
During the fiscal year, a total of 23,200 shares underlying the first through fifth series of stock acquisition rights were exercised, leaving a total of 85,720 unexercised shares. - FY2024-Q2AdvancedAnnual report
「Stock options structured as stock compensation for the Company’s directors, excluding outside directors Resolution date 27 June 2023 Category and number of grantees (people) The Company’s directors, excluding outside directors 5 Number of stock acquisition rights ※ 2,438 Class, description and number of shares underlying the stock acquisition rights ※ Common shares 24,380」
Based on the resolution dated 27 June 2023, 2,438 stock acquisition rights, representing 24,380 underlying shares, were issued to 5 directors. The exercise period runs from 1 August 2023 to 31 July 2043, and the exercise price is ¥1 per share. - FY2023RestatedAnnual report
「The Company grants stock options structured as stock compensation to directors responsible for executing operations, in principle annually at a specified time, with the aim of strengthening directors’ incentives to improve corporate performance and their management focus on shareholders.」
The Company continues its policy of granting stock options structured as stock compensation to directors in principle every year. - FY2021RestatedAnnual report
「The Company grants stock options structured as stock compensation to directors responsible for executing operations, in principle annually at a specified time, with the aim of strengthening directors’ incentives to improve corporate performance and their management focus on shareholders.」
The Company stated its policy of granting stock options structured as stock compensation to directors in principle every year. - FY2020-Q2AdvancedAnnual report
「Stock options structured as stock compensation for the Company’s directors, excluding outside directors」
Based on the resolution dated 26 June 2019, 2,772 stock acquisition rights, representing 27,720 underlying shares, were issued to 4 directors. The exercise period runs from 1 August 2019 to 31 July 2039, and the exercise price is ¥1 per share. - FY2019RestatedAnnual report
「Resolution date 27 June 2018 (Note) Category and number of grantees (people) The Company’s directors, excluding outside directors 5 Number of stock acquisition rights ※ 1,995」
As of the end of the fiscal year, the Company continued to report 1,995 stock acquisition rights, representing 19,950 underlying shares, granted to 5 directors under the third stock-compensation stock option plan. - FY2019-Q2AdvancedAnnual report
「Stock options structured as stock compensation for the Company’s directors, excluding outside directors」
Based on the resolution dated 27 June 2018, 1,995 stock acquisition rights, representing 19,950 underlying shares, were issued to 5 directors. The exercise period runs from 1 August 2018 to 31 July 2038, and the exercise price is ¥1 per share. - FY2018-Q2First statedAnnual report
「Stock options structured as stock compensation for the Company’s directors, excluding outside directors」
Based on the resolution dated 27 June 2017, 2,070 stock acquisition rights, representing 20,700 underlying shares, were issued to directors. The exercise period runs from 1 August 2017 to 31 July 2037, and the exercise price is ¥1 per share.